Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience.
Ann Hematol
; 90(5): 557-68, 2011 May.
Article
in En
| MEDLINE
| ID: mdl-20938660
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Receptors, CXCR4
/
Hematopoietic Stem Cell Mobilization
/
Compassionate Use Trials
/
Heterocyclic Compounds
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
Ann Hematol
Journal subject:
HEMATOLOGIA
Year:
2011
Document type:
Article
Affiliation country:
Country of publication: